MedTrace Logo

How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?

NCT00798694 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2018-07-12

Study results available
· View outcomes & findings →

Summary

To determine whether one glaucoma eye drop is less likely to cause changes to the surface of the eye (conjunctiva) than another. The two different prostaglandins are Xalatan and Travatan Z.

Conditions

Interventions

DRUG

Xalatan

one drop of Xalatan Ophthalmic Solution instilled in right eye at bedtime

DRUG

Travatan Z

one drop of Travatan Z Ophthalmic Solution instilled in left eye at bedtime

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Wills Eye

    lead OTHER

Principal Investigators

  • Leslie J Katz, MD · Wills Eye Glaucoma Service

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2011-01-31
Completion
2011-02-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00798694 on ClinicalTrials.gov